Kendler KS, Myers J. Clinical indices of familial alcohol use disorder. Alcohol Clin Exp Res 2012; 36:2126–31. doi:10.1111/j.1530-0277.2012.01844.x
Ciafre S, Fiore M, Ceccanti M, Messina MP, Tirassa P, Carito V. Role of neuropeptide tyrosine (NPY) in ethanol addiction. Biomed Rev 2016; 27:27–39. doi:10.14748/bmr.v27.2110
Ciafrè S, Carito V, Tirassa P, Ferraguti G, Attilia ML, Ciolli P, et al. Ethanol consumption and innate neuroimmunity. Biomed Rev 2017; 28:49–61. doi:10.14748/bmr. v28.4451
Ceccanti M, Carito V, Vitali M, Iannuzzi S, Tarani L, De Nicolo S, et al. Serum BDNF and NGF Modulation by Olive Polyphenols in Alcoholics during Withdrawal. J Alcohol Drug Depend 2015; 03: doi:10.4172/2329-6488.1000214
Uchtenhagen AA. Heroin maintenance treatment: from idea to research to practice. Drug Alcohol Rev 2011; 30:130–7. doi:10.1111/j.1465-3362.2010.00266.x
Ciafre’ S, Carito V, Ferraguti G, Greco A, Chaldakov GN, Fiore M, Ceccanti M. How alcohol drinking affects our genes: an epigenetic point of view. Biochem Cell Biol 2019; bcb-2018-0248. doi:10.1139/bcb-2018-0248
Ceccanti M, Iannitelli A, Fiore M. Italian Guidelines for the treatment of alcohol dependence. Riv Psichiatr 2018; 53:105–106. doi:10.1708/2925.29410
Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict Behav 1998; 23:717–34.
Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev 2000; 20:173–89.
Lev-Ran S, Balchand K, Lefebvre L, Araki KF, Le Foll B. Pharmacotherapy of alcohol use disorders and concurrent psychiatric disorders: a review. Can J Psychiatry 2012; 57:342–9.
Pettinati HM, O’Brien CP, Dundon WD. Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry 2013; 170:23–30. doi:10.1176/appi.ajp.2012.12010112
Atkinson R, Misra S. Mental disorders and symptoms in older alcoholics. In: Treating Alcohol and Drug Abuse in the Elderly. AM Gurnack, R Atkinson, NJ Osgood, eds. New York, Springer, (2002) pp 50–71.
Bates ME, Buckman JF, Nguyen TT. A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychol Rev 2013; 23:27–47. doi:10.1007/s11065-013-9228-3
Ceccanti M, Coriale G, Hamilton DA, Carito V, Coccurello R, Scalese B, et al. Virtual Morris task responses in individuals in an abstinence phase from alcohol. Can J Physiol Pharmacol 2018; 96:128–136. doi:10.1139/cjpp-2017-0013
Ceccanti M, Hamilton D, Coriale G, Carito V, Aloe L, Chaldakov G, et al. Spatial learning in men undergoing alcohol detoxification. Physiol Behav 2015; 149:324–330. doi:10.1016/j.physbeh.2015.06.034
Hesselbrock VM, Hesselbrock MN. Are there empirically supported and clinically useful subtypes of alcohol dependence? Addiction 2006; 101 Suppl:97–103. doi:10.1111/j.1360-0443.2006.01596.x
Coriale G, Fiorentino D, De Rosa F, Solombrino S, Scalese B, Ciccarelli R, et al. Treatment of alcohol use disorder from a psychological point of view. Riv Psichiatr 2018; 53:141–148. doi:10.1708/2925.29416
Coriale G, Fiorentino D, Porrari R, Battagliese G, Capriglione I, Cereatti F, et al. Diagnosis of alcohol use disorder from a psychological point of view. Riv Psichiatr 2018; 53:128–140. doi:10.1708/2925.29415
Alterman AI, McDermott PA, Cook TG, Metzger D, Rutherford MJ, Cacciola JS, et al. New scales to assess change in the Addiction Severity Index for the opioid, cocaine, and alcohol dependent. Psychol Addict Behav 1998; 12:233–246.
Ceccanti M, Inghilleri M, Attilia ML, Raccah R, Fiore M, Zangen A, Ceccanti M. Deep TMS on alcoholics: effects on cortisolemia and dopamine pathway modulation. A pilot study. Can J Physiol Pharmacol 2015; 93:283–290. doi:10.1139/cjpp-2014-0188
Strong WA. Alcoholism, its frequency, etiology and treatment. Psychiatr Q 1940; 14:403–411. doi:10.1007/BF01573198
Anthenelli RM. Overview: stress and alcohol use disorders revisited. Alcohol Res 2012; 34:386–90.
Breese GR, Sinha R, Heilig M. Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol Ther 2011; 129:149–71. doi:10.1016/j.pharmthera.2010.09.007
Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 2001; 158:343–359. doi:10.1007/s002130100917
Sinha R. How does stress lead to risk of alcohol relapse?Alcohol Res 2012; 34:432–40.
Project MATCH Research Group. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997; 58:7–29.
GROUP PMR. Matching patients with alcohol disorders to treatments: Clinical implications from Project MATCH. J Ment Heal 1998; 7:589–602. doi:10.1080/09638239817743
McLellan AT, Grissom GR, Brill P, Durell J, Metzger DS, O’Brien CP. Private substance abuse treatments: are some programs more effective than others? J Subst Abuse Treat 1994; 10:243–54.
Kadden RM. Behavioral and cognitive-behavioral treatments for alcoholism: research opportunities. Addict Behav 1994; 26:489–507.
Miller WR, Rollnick S. Motivational interviewing: Preparing people to change addictive behavior. New York: Guildford Press (1991).
Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. Guilford Press (2002).
Dobson KS. Handbook of Cognitive-Behavioral Therapies, Second Edition. Guilford Press (2002).
Marlatt GA. Taxonomy of high-risk situations for alcohol relapse: evolution and development of a. Addiction 1996; 91:37–50. doi:10.1080/09652149638791
Khan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, El-Serag HB, Kanwal F. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review. Clin Gastroenterol Hepatol 2016; 14:191–202.e4. doi:10.1016/j.cgh.2015.07.047
Pettinati HM, Anton RF, Willenbring ML. The COMBINE Study-: An Overview of the Largest Pharmacotherapy Study to Date for Treating Alcohol Dependence. Psychiatry 2006; 3:36–9.
UKATT Research Team. Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ 2005;331:544. doi:10.1136/bmj.331.7516.544
Marlatt GA, Gordon JR. Relapse Prevention. New York: The Guilford Press (1985).
Marlatt GA, Donovan DM. Relapse prevention: Maintenance strategies in the treatment of addictive behaviors (2nd ed.). New York, NY, US: The Guilford Press (2005).
Carroll KM. Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Exp Clin Psychopharmcology 1996; 41:46–54.
Monti PM, Gulliver SB, Myers MG. Social skills training for alcoholics: assessment and treatment. Alcohol Alcohol 1994; 29:627–37.
Sibilia L, Ceccanti M, Deiana L, Di Girolamo E. Il progetto Agata: psicologia cognitivo-comportamentale per la prevenzione secondaria dell’abuso alcoolico. Psicoter Cogn e Comport 2000; 6:123–137.
Sibilia L, Ceccanti M, Deiana L, Coriale G, Picozzi R. Maintenance of abstinence from alcohol. Lancet 2001; 358:1103–4. doi: 10.1016/s0140-6736(01)06222-5
Khan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, et al. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review. Clin Gastroenterol Hepatol 2016; 14:191–202. e4. doi:10.1016/j.cgh.2015.07.047
United Kingdom Alcohol Treatment Trial (UKATT): hypotheses, design and methods. Alcohol Alcohol 2001; 36:11–21. doi:10.1093/alcalc/36.1.11
Holder H, Longabaugh R, Miller WR, Rubonis A V. The cost effectiveness of treatment for alcoholism: a first approximation. J Stud Alcohol 1991; 52:517–40. doi: 10.1093/alcalc/33.6.563
Lejoyeux M, Solomon J, Adès J. Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol 1998; 33:563–75. doi: 10.1093/alcalc/33.6.563
APA. Diagnostic and Statistical Manual of Mental Disorders: Dsm-5. 5th ed. Amer Psychiatric Pub Incorporated (2013).
Derogatis LR. SCL-90-R: Symptom Checklist-90-R : Administration, Scoring, and Procedures Manual. NCS Pearson (1996).
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–98. doi: 10.1016/0022-3956(75)90026-6
David Wechsler. Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV). ed. Pearson Education (2008).
Arnau MM, Gual A. Attrition in group therapy with alcoholics: a survival analysis. Drug Alcohol Rev 2000; 19:55–63. doi:10.1080/09595230096156
Fonsi Elbreder M, de Souza e Silva R, Pillon SC, Laranjeira R. Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment. Alcohol Alcohol 2011; 46:74–6. doi:10.1093/alcalc/agq078
Mackay PW, Marlatt GA. Maintaining sobriety: stopping is starting. Int J Addict 1991; 25:1257–76. doi: 10.3109/10826089109081045
Ledda R, Battagliese G, Attilia F, Rotondo C, Pisciotta F, Gencarelli S, et al. Drop-out, relapse and abstinence in a cohort of alcoholic people under detoxification. Physiol Behav 2019; 198:67–75. doi:10.1016/j. physbeh.2018.10.009
Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 2002; 97:265–77. doi: 10.1046/j.1360-0443.2002.00019.x
Ceylan-Isik AF, McBride SM, Ren J. Sex difference in alcoholism: Who is at a greater risk for development of alcoholic complication? Life Sci 2010; 87:133–138. doi:10.1016/j.lfs.2010.06.002
Holmila M, Raitasalo K. Gender differences in drinking: why do they still exist? Addiction 2005; 100:1763–1769. doi:10.1111/j.1360-0443.2005.01249.x
Greenfield SF, Pettinati HM, O’Malley S, Randall PK, Randall CL. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study. Alcohol Clin Exp Res 2010; 34:1803–12. doi:10.1111/j.1530-0277.2010.01267.x
Litt MD, Kadden RM, Tennen H. Network Support treatment for alcohol dependence: gender differences in treatment mechanisms and outcomes. Addict Behav 2015; 45:87–92. doi:10.1016/j.addbeh.2015.01.005
Mancinelli R, Vitali M, Ceccanti M. Women, alcohol and the environment: an update and perspectives in neuroscience. Funct Neurol 2009; 24:77–81.
Mancinelli R, Binetti R, Ceccanti M. Woman, alcohol and environment: Emerging risks for health. Neurosci Biobehav Rev 2007; 31:246–253. doi: 10.1016/j. neubiorev.2006.06.017
Ferraguti G, Ciolli P, Carito V, Battagliese G, Mancinelli R, Ciafrè S, et al. Ethylglucuronide in the urine as a marker of alcohol consumption during pregnancy: Comparison with four alcohol screening questionnaires. Toxicol Lett 2017; 275:49–56. doi:10.1016/j.toxlet.2017.04.016
Coriale G, Fiorentino D, Lauro F Di, Marchitelli R, Scalese B, Fiore M, et al. Fetal Alcohol Spectrum Disorder (FASD): neurobehavioral profile, indications for diagnosis and treatment Fetal Alcohol Spectrum Disorder (FASD): profilo neuro-comportamentale, diagnosi differenziale e indicazioni per il trattamento. Riv Psichiatr 2013; 48:359–369. doi: 10.1708/1356.15062
Carito V, Ceccanti M, Ferraguti G, Coccurello R, Ciafrè S, Tirassa P, Fiore M. NGF and BDNF Alterations by Prenatal Alcohol Exposure. Curr Neuropharmacol 2019; 17(4):308-317. doi:10.2174/1570159X15666170825101308
De Nicolò S, Carito V, Fiore M, Laviola G. Aberrant Behavioral and Neurobiologic Profiles in Rodents Exposed to Ethanol or Red Wine Early in Development. Curr Dev Disord Reports 2014; 1:173–180. doi:10.1007/s40474-014-0023-5
Ferraguti G, Merlino L., Battagliese G., Piccioni MG., Barbaro G., Carito V., et al. Fetus morphology changes by second-trimester ultrasound in pregnant women drinking alcohol. Addict Biol 2019; doi:10.1111/adb.12724
Ceccanti M, Fiorentino D, Coriale G, Kalberg WO, Buckley D, Hoyme HE, et al. Maternal risk factors for fetal alcohol spectrum disorders in a province in Italy. Drug Alcohol Depend 2014; 145:201–208. doi:10.1016/j. drugalcdep.2014.10.017
Kodituwakku P, Coriale G, Fiorentino D, Aragón AS, Kalberg WO, Buckley D, et al. Neurobehavioral characteristics of children with fetal alcohol spectrum disorders in communities from Italy: Preliminary results. Alcohol Clin Exp Res 2006; 30:1551–1561. doi:10.1111/j.1530-0277.2006.00187.x
Coriale G, Fiorentino D, Kodituwakku PW, Tarani L, Parlapiano G, Scalese B, Ceccanti M. Identification of Children With Prenatal Alcohol Exposure. Curr Dev Disord Reports 2014; 1:141–148. doi:10.1007/s40474-014-0018-2
Ceccanti M, Mancinelli R, Tirassa P, Laviola G, Rossi S, Romeo M, Fiore M. Early exposure to ethanol or red wine and long-lasting effects in aged mice. A study on nerve growth factor, brain-derived neurotrophic factor, hepatocyte growth factor, and vascular endothelial growth factor. Neurobiol Aging 2012; 33:359–367. doi:10.1016/j. neurobiolaging.2010.03.005
Angelucci F, Fiore M, Cozzari C, Aloe L. Prenatal ethanol effects on NGF level, NPY and ChAT immunoreactivity in mouse entorhinal cortex: A preliminary study. Neurotoxicol Teratol 1999; 21:415–425. doi:10.1016/S0892-0362(99)00005-7
Ceccanti M, Coccurello R, Carito V, Ciafrè S, Ferraguti G, Giacovazzo G, et al. Paternal alcohol exposure in mice alters brain NGF and BDNF and increases ethanol-elicited preference in male offspring. Addict Biol 2016; 21:776–787. doi:10.1111/adb.12255
Ceccanti M, De Nicolò S, Mancinelli R, Chaldakov G, Carito V, Ceccanti M, et al. NGF and BDNF long-term variations in the thyroid, testis and adrenal glands of a mouse model of fetal alcohol spectrum disorders. Ann Ist Super Sanita 2013; 49:383–390. doi:10.4415/ANN-13-04-11
Fiore M, Mancinelli R, Aloe L, Laviola G, Sornelli F, Vitali M, Ceccanti M. Hepatocyte growth factor, vascular endothelial growth factor, glial cell-derived neurotrophic factor and nerve growth factor are differentially affected by early chronic ethanol or red wine intake. Toxicol Lett 2009; 188:208–213. doi:10.1016/j.toxlet.2009.04.013
Fiore M, Laviola G, Aloe L, di Fausto V, Mancinelli R, Ceccanti M. Early exposure to ethanol but not red wine at the same alcohol concentration induces behavioral and brain neurotrophin alterations in young and adult mice. Neurotoxicology 2009; 30:59–71. doi:10.1016/j. neuro.2008.11.009
Del Boca FK, Darkes J. The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 2003; 98 (Suppl 2):1–12.
Riper H, Andersson G, Hunter SB, de Wit J, Berking M, Cuijpers P. Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis. Addiction 2014; 109:394–406. doi:10.1111/add.12441
Rehm J, Baliunas D, Borges GLG, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 2010; 105:817–843. doi:10.1111/j.1360-0443.2010.02899.x
Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J, et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373:2223–33. doi:10.1016/S0140-6736(09)60746-7
Ridolfo B, Stevenson C. The Quantification of Drug-Caused Mortality and Morbidity in Australia 1998. Canberra: Australian Institute of Health and Welfare. 2001.
Ciafrè S, Carito V, Ferraguti G, Greco A, Ralli M, Chaldakov GN, et al. Nerve growth factor in brain diseases. Biomed Rev 2018; 29: 1-16. doi: .org/10.14748/bmr.v29.5845
Carito V, Parlapiano G, Rasio D, Papaella R, Paolucci V, Ferraguti G, et al. Fetal Alcohol spectrum disorders in pediatrics. Biomed Rev 2018; 29: 27-35. doi: .org/10.14748/bmr.v29.5847
Tarani L, Micangeli G, Rasio D, Ottombrino S, Liberati N, De Angelis D, et al. Clinical and genetica approach to the dysmorphic child. Biomed Rev 2018; 29: 37-46. doi:10.14748/bmr.v29.5848
Coriale G, Battagliese G, Pisciotta F, Attilia ML, Porrari R, De Rosa F, et al. Behavioral responses in people affected by alcohol use disorder and psychiatric comorbidity: correlations with addiction severity. Ann Ist Super Sanita 2019; 55:131-142. doi: 10.4415/ANN_19_02_05.
Email this article (Login required) 
